Food scares and drug scandals have raised serious concerns over the F.D.A.’s ability to regulate effectively. A look at the resources and direction at the Food and Drug Administration, and why some are hoping for significant changes under the next administration.


  • Gardiner Harris science reporter for "The New York Times"
  • Rep. Rosa DeLauro U.S. Congresswoman, representing Connecticut's 3rd district; chairwoman of the Agriculture-FDA Appropriations Subcommittee
  • William Hubbard former associate commissioner for the Food and Drug Administration; spokesperson for the Alliance for a Stronger FDA
  • Alan Goldhammer, PhD associate vice president for regulatory affairs at the Pharmaceutical Research and Manufacturers of America (PhRMA)
  • Dr. Sidney Wolfe director of the Health Research Group at Public Citizen; editor of

Topics + Tags


comments powered by Disqus
Most Recent Shows

Readers’ Review: “My Brilliant Friend” by Elena Ferrante

Wednesday, Nov 25 2015"My Brilliant Friend" by Elena Ferrante is the first of the mysterious Italian author's Neapolitan novels. The series tells the story of a life-long friendship between two working class girls in Naples. Critics have called Ferrante “one of the greatest novelists of our time.” Yet nobody knows her true identity. Join Diane and her guests for a discussion of “My Brilliant Friend.”

International Military Action In Syria

Wednesday, Nov 25 2015French President Hollande meets with President Obama in Washington to seek additional U.S. support in the fight against ISIS in Syria, and NATO holds an emergency meeting over the downed Russian fighter jet: An update on international military strategy in Syria.